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Tsc1-mTORC1 signaling controls striatal dopamine
release and cognitive flexibility
Polina Kosillo 1, Natalie M. Doig 2, Kamran M. Ahmed 1, Alexander H.C.W. Agopyan-Miu1,
Corinna D. Wong1, Lisa Conyers 2, Sarah Threlfell3,4, Peter J. Magill 2,4 & Helen S. Bateup 1,5,6*
Tuberous Sclerosis Complex (TSC) is a neurodevelopmental disorder caused by mutations in
TSC1 or TSC2, which encode proteins that negatively regulate mTOR complex 1 (mTORC1).
TSC is associated with significant cognitive, psychiatric, and behavioral problems, collectively
termed TSC-Associated Neuropsychiatric Disorders (TAND), and the cell types responsible
for these manifestations are largely unknown. Here we use cell type-specific Tsc1 deletion to
test whether dopamine neurons, which modulate cognitive, motivational, and affective
behaviors, are involved in TAND. We show that loss of Tsc1 and constitutive activation of
mTORC1 in dopamine neurons causes somatodendritic hypertrophy, reduces intrinsic
excitability, alters axon terminal structure, and impairs striatal dopamine release. These
perturbations lead to a selective deficit in cognitive flexibility, preventable by genetic
reduction of the mTOR-binding protein Raptor. Our results establish a critical role for Tsc1-
mTORC1 signaling in setting the functional properties of dopamine neurons, and indicate that
dopaminergic dysfunction may contribute to cognitive inflexibility in TSC.
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The mechanistic target of rapamycin (mTOR) is a ubiqui-tously expressed, conserved signaling cascade that inte-grates intra- and extracellular signals to regulate cellular
metabolism and growth1. Deregulation of mTOR signaling is
linked to numerous diseases, with particularly detrimental out-
comes for nervous system development and function2,3. mTOR
functions as a kinase within two complexes, mTORC1 and
mTORC2, that have distinct protein components, upstream
activators, and downstream targets4. Activation of mTORC1
promotes anabolic functions, including protein and lipid synth-
esis, and suppresses autophagy, leading to cell growth and divi-
sion1. mTORC1 activity is negatively regulated by the
heterodimeric Tsc1/2 protein complex that exerts GTP-ase-
activating (GAP) activity on the small GTP-ase Rheb, a direct
activator of mTORC15. Disruption of the Tsc1/2 complex results
in constitutively active mTORC1, leading to altered cell growth,
metabolism, and proliferation5.
In post-mitotic neurons, Tsc1/2-mTORC1 signaling controls
neuronal communication in a cell type-specific manner via reg-
ulation of membrane excitability, synaptic transmission, and
synaptic plasticity6–15. Loss-of-function mutations in negative
regulators of mTORC1 cause neurodevelopmental syndromes
associated with significant neurological and psychiatric impair-
ments. In particular, tuberous sclerosis complex (TSC), which
results from mutations in TSC1 or TSC2, causes early-onset
epilepsy16. In addition, patients frequently present with neu-
ropsychiatric conditions, including autism spectrum disorder
(ASD), attention deficit hyperactivity disorder (ADHD), affective
disorders, and cognitive deficits, collectively termed TAND (TSC-
associated neuropsychiatric disorders)17. TAND is a major bur-
den for patients17; however, little is known about how mutations
in TSC1/2 cause neuropsychiatric and behavioral abnormalities.
In particular, the specific neuronal populations responsible for
TAND and the functional consequences of mTOR pathway
mutations on these neurons remain to be defined.
Midbrain dopamine (DA) neurons of the substantia nigra pars
compacta (SNc) and ventral tegmental area (VTA) modulate a
host of motivated behaviors18–21. Given the involvement of DA
signaling in many of the neuropsychiatric conditions associated
with TSC, we hypothesized that changes in DA signaling may
contribute to TAND. To test this, we selectively deleted Tsc1 from
mouse DA neurons. This cell type-targeted approach allowed us
to test whether constitutive activation of mTORC1 signaling in
DA neurons alone was sufficient to drive TAND-related
phenotypes.
Here we find that DA neurons are particularly sensitive to
changes in mTORC1 signaling, as chronic activation of mTORC1
due to Tsc1 loss profoundly affects their structure and function
resulting in significant impairments in striatal DA release. This
dopaminergic deficit is associated with reduced cognitive flex-
ibility in the absence of changes to motor or social behaviors. Our
findings pinpoint mTORC1 as a critical regulator of midbrain DA
neuron output and suggest that cognitive inflexibility in mTOR-
related disorders may involve changes in DA signaling.
Results
Loss of Tsc1 causes DA neuron somatodendritic remodeling.
The goal of this study was to test the sufficiency of manip-
ulating mTORC1 signaling in DA neurons to drive cellular and
behavioral phenotypes relevant to TAND. To do this, we con-
ditionally deleted Tsc122, which results in loss of function of
the Tsc1/2 complex, from DA neurons using DATIRESCre
mice23. Mice were heterozygous for DATIRESCre and had either
wild-type (DA-Tsc1 WT) or homozygous floxed alleles of Tsc1
(DA-Tsc1 KO) (Supplementary Fig. 1a, b). We quantified
phosphorylation of the mTORC1 pathway target ribosomal
protein S6 (p-S6) in tyrosine hydroxylase (TH)-labeled SNc and
VTA neurons as a read-out of mTORC1 activity (Fig. 1a–e and
Supplementary Fig. 1c, d). p-S6 levels were significantly higher
in DA-Tsc1-KO neurons (Fig. 1e and Supplementary Fig. 1d),
indicative of activated mTORC1 signaling. Consistent with the
known function of mTORC1 in controlling cell size1, loss of
Tsc1 caused a profound increase in DA neuron soma area
(Fig. 1f and Supplementary Fig. 1e).
In addition to somatic hypertrophy, altered dendrite branching
has been observed in neurons with mutations in mTORC1
regulators9,14,24–27. We performed Sholl analysis of neurobiotin-
filled neurons (Supplementary Fig. 1f) and found that SNc and
VTA DA neurons in DA-Tsc1-KO mice had more complex
dendrites and increased total dendritic length (Fig. 1g–i and
Supplementary Fig. 1g–i). Together, these data demonstrate that
loss of Tsc1 strongly impacts the somatodendritic architecture of
midbrain DA neurons.
Tsc1 loss from DA neurons reduces intrinsic excitability. To
test whether the extensive somatodendritic remodeling in DA-
Tsc1-KO neurons resulted in a change to their membrane
properties, we performed whole-cell recordings from DA neurons
identified by a Cre-dependent tdTomato reporter28 (Supple-
mentary Fig. 1b). Consistent with their hypertrophy, SNc and
VTA DA-Tsc1-KO neurons had significantly increased mem-
brane capacitance and decreased membrane resistance compared
to WT neurons (Fig. 1j, k, Supplementary Fig. 1j, k, and Sup-
plementary Tables 1 and 2). In response to hyperpolarization,
midbrain DA neurons often exhibit a membrane potential sag
mediated by hyperpolarization-activated cyclic nucleotide-gated
(HCN) channels29. Although the absolute sag amplitude was
significantly reduced in DA-Tsc1-KO neurons (Fig. 1l, Supple-
mentary Fig. 1l), when expressed as a percentage of the maximum
hyperpolarization from baseline, there was no difference between
genotypes (Fig. 1m, Supplementary Fig. 1m and Supplementary
Tables 1 and 2). This suggests that DA-Tsc1-KO neurons have
normal HCN activation, but that changes in their passive mem-
brane properties affect their overall response to hyperpolarizing
current.
To measure intrinsic excitability, we injected steps of
depolarizing current to generate excitability curves and found
that SNc and VTA DA-Tsc1-KO cells were hypoexcitable
(Fig. 2a–c, Supplementary Fig. 1n–p, and Supplementary Tables 1
and 2). Significantly more current was required to evoke action
potential (AP) firing in DA-Tsc1-KO neurons (Fig. 2b and
Supplementary Fig. 1o). At current step amplitudes up to 400 pA,
DA-Tsc1-KO neurons fired fewer APs than DA-Tsc1-WT
neurons; however, at ≥500 pA current, DA-Tsc1-KO neurons
had similar or increased firing (Fig. 2c and Supplementary
Fig. 1p). Thus, more current is required to drive spiking in DA-
Tsc1-KO neurons, but these neurons may be able to fire a burst of
APs given a sufficiently large excitatory input.
DA neurons have been classically defined by their relatively
long AP duration and prominent after-hyperpolarization30. We
examined the properties of single APs evoked by positive current
injection and found that Tsc1 deletion substantially changed the
AP waveform (Fig. 2d, e, Supplementary Fig. 1q, r and
Supplementary Tables 1 and 2). Specifically, the AP duration of
SNc and VTA DA-Tsc1-KO neurons was significantly shorter
(Fig. 2f and Supplementary Fig. 1s), which may be due to altered
potassium channels that control repolarization31. These electro-
physiology changes are similar to those of Tsc1-KO thalamic
neurons, which also showed altered passive membrane properties
and shorter duration APs11.
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Tsc1 loss impairs striatal DA release. The AP firing of DA
neurons does not linearly translate into axonal DA release32,33.
Therefore, to test how loss of Tsc1 affects DA output, we used
fast-scan cyclic voltammetry (FCV) to monitor electrically evoked
DA release in the striatum. We found a significant decrease in the
peak amplitude of evoked extracellular DA ([DA]o) released
throughout the dorsal striatum and, to a lesser extent, in the
nucleus accumbens (NAc) core, in DA-Tsc1-KO mice (Fig. 3a, b).
Decreased DA release was found with both single-pulse (Fig. 3a,
b) and high-frequency burst stimulation (four pulses at 100 Hz,
Supplementary Fig. 2a, b). Combining all dorsal striatal sites, we
found an average 60% reduction in single pulse (Fig. 3c, d) and
45% reduction in high-frequency burst-evoked [DA]o (Supple-
mentary Fig. 2c, d). We tested multiple electrical stimulation
intensities and found that DA release deficits in DA-Tsc1-KO
slices were exacerbated at low currents, consistent with their
intrinsic hypoexcitability, while peak-evoked [DA]o plateaued at
similar stimulation intensities as in WT slices (Supplementary
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Fig. 1 DA-Tsc1-KO SNc neurons are hypertrophic. a–d Confocal images of midbrain sections from DA-Tsc1-WT (a, b) and DA-Tsc1-KO (c, d) mice
labeled with antibodies against tyrosine hydroxylase (TH) and phosphorylated S6 (p-S6, Ser240/244), scale bars= 200 μm. b, d show higher
magnification merged images of the boxed regions in a, c, scale bars= 50 μm. e, f Cumulative probability plots of SNc DA neuron p-S6 levels (e) and soma
area (f) (DA-Tsc1 WT: n= 759 neurons from three mice, DA-Tsc1 KO: n= 855 neurons from three mice). ****p < 0.0001, Kolmogorov–Smirnov tests.
g Three-dimensional reconstructions of SNc DA neurons. h Sholl analysis of SNc DA neurons. Dark colored lines are the mean, lighter color shading
represents SEM (DA-Tsc1 WT: n= 19 neurons from five mice, DA-Tsc1 KO: n= 30 neurons from nine mice). Two-way ANOVA p values are shown.
i Mean ± SEM total dendritic length per cell (DA-Tsc1 WT: n= 19 neurons from five mice, DA-Tsc1 KO: n= 30 neurons from nine mice). ****p < 0.0001,
Welch’s two-tailed t test. j, kMean ± SEM membrane capacitance (j), and membrane resistance (k) (DA-Tsc1 WT: n= 18 neurons from five mice, DA-Tsc1
KO: n= 31 neurons from nine mice). ****p < 0.0001, Welch’s two-tailed t test (j) or Mann–Whitney test (k). l Example current-clamp recordings from SNc
DA neurons in response to a −100 pA current step. m Mean ± SEM sag amplitude expressed as a percentage of the maximum hyperpolarization from
baseline (DA-Tsc1 WT: n= 18 neurons from five mice, DA-Tsc1 KO: n= 31 neurons from nine mice). p= 0.0941, unpaired two-tailed t test. For all bar
graphs, dots represent values for individual neurons. See also Supplementary Fig. 1 and Supplementary Tables 1 and 2. Source data are provided as a Source
Data file.
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Fig. 2e). Notably, the dorsal striatal release deficits in DA-Tsc1-
KO mice did not deteriorate further in aged animals and
remained ~60% below WT levels in 22-month-old mice (Sup-
plementary Fig. 2f–h).
Striatal DA release is tightly regulated by striatal cholinergic
interneurons (ChIs)32,33. Therefore, we repeated the FCV
experiments with cholinergic transmission blockers to test for
potential involvement of ChIs in the release phenotypes
(Supplementary Fig. 2i). We found that release deficits in DA-
Tsc1-KO slices generally persisted after blockade of cholinergic
transmission (Fig. 3c, d and Supplementary Fig. 2c, d),
confirming a cell autonomous effect on DA neuron function.
Autoreceptor occupancy and calcium sensitivity are unaltered.
One possible mechanism for a reduction in striatal [DA]o is
increased activity or expression of type 2 DA (D2) autoreceptors
on DA axons, which inhibit DA release33,34 (Supplementary
Fig. 2j). Application of the D2 receptor agonist quinpirole
decreased peak-evoked [DA]o to a similar extent in DA-Tsc1-WT
and DA-Tsc1-KO slices (WT half-maximal inhibitory con-
centration (IC50)= 102.7 ± 0.79 nM, KO IC50= 115.9 ± 0.81 nM,
Fig. 3e, f). Therefore, it is unlikely that changes in D2 auto-
receptor function account for the impairment in evoked DA
release.
Striatal DA release is dependent on voltage-gated calcium
channels and is thus sensitive to changes in extracellular calcium
levels32,33. We tested if increasing extracellular calcium could
ameliorate release deficits. As expected, increasing extracellular
calcium to 5 mM led to increased peak-evoked [DA]o in both
genotypes compared to normal 2.4 mM Ca2+. However, dorsal
striatal DA release in DA-Tsc1-KO slices remained ~60% lower
than in WT slices (Fig. 3g, h). We conclude that altered calcium
sensitivity is unlikely to be a primary contributor to the release
deficits observed.
DA release probability is decreased following Tsc1 deletion.
The amount of DA released upon stimulation is dependent upon
release probability (Pr)35,36. While DA neurons have distinct
release machinery and properties compared to fast-acting neu-
rotransmitters37, an estimate of DA Pr can be generated by
examining the responses to multiple stimuli36. We measured the
paired-pulse ratio of dorsal striatal release events evoked by single
stimuli delivered 3 s apart, in the presence of dihydro-β-
erythroidine (DHβE) to remove cholinergic modulation and
5 mM Ca2+ to maximize Pr (Fig. 4a). The second-to-first peak
ratio was significantly higher in DA-Tsc1-KO slices (Fig. 4b),
indicative of a reduction in initial Pr. We also compared the ratio
of peak [DA]o evoked by four stimuli delivered at 100 Hz to that
evoked by a single pulse (4p/1p ratio) in the dorsal striatum
(Fig. 4c). The 4p/1p ratio was significantly higher in DA-Tsc1-KO
slices compared to WT across experimental conditions (Fig. 4d).
These results are again consistent with reduced initial Pr, a con-
clusion supported by the increased frequency-response sensitivity
observed in DA-Tsc1-KO slices (Supplementary Fig. 2k).
In the course of the FCV experiments, we observed that the
clearance of [DA]o, which is mediated by re-uptake of DA back
into the axon terminal by the DA active transporter (DAT), was
faster in DA-Tsc1-KO slices (Supplementary Fig. 2l, m). This
enhanced re-uptake, combined with the initial release deficit due
to reduced Pr, indicates that loss of Tsc1 from DA neurons
strongly impairs their ability to influence dorsal striatal targets.
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DA production is increased following Tsc1 loss. We next
investigated whether the reduction in evoked DA release was a
result of decreased numbers of DA neurons, reduced striatal
innervation, and/or impaired DA production. At 3 months of age,
the number of DA neurons in the midbrain was not significantly
different between littermate DA-Tsc1-WT and DA-Tsc1-KO mice
(Fig. 5a–c, p= 0.4343, unpaired, two-tailed t test). Therefore,
deletion of Tsc1 around embryonic day 1723 does not strongly
impact the differentiation or survival of DA neurons into adult-
hood. We next examined whether striatal axons in DA-Tsc1-KO
mice had the capacity to synthesize and package DA. We found
that dopaminergic innervation of both the dorsal and ventral
striatum was intact and expression of the vesicular monoamine
transporter-2 (VMAT-2), responsible for packaging DA into
vesicles, was normal in total striatal homogenates (Fig. 5d, e).
Interestingly, we found that DA-Tsc1-KO striatal axons and DA
cell bodies in both the SNc and VTA had higher expression of TH,
the rate-limiting enzyme in DA synthesis (Fig. 5d–m, o–v). We
tested whether higher TH levels resulted in increased DA synthesis
by analyzing total tissue DA content using high-performance
liquid chromatography (HPLC). The total content of DA was
significantly elevated in DA-Tsc1-KO mice in both dorsal and
ventral striatal regions, while levels of the primary DA metabolite
3,4-dihydroxyphenylacetic acid (DOPAC) were not significantly
affected (Fig. 5n, w). Since the ratio of DOPAC to DA per mouse
was unchanged by loss of Tsc1 (Fig. 5n, w), we conclude that the
high DA levels were due to increased DA synthesis rather than
reduced turnover.
Loss of Tsc1 alters DA axon ultrastructure. Our analyses
revealed a strong impairment in dorsal but not ventral striatal DA
release (see Fig. 3) despite elevated DA tissue content in both
regions (see Fig. 5). This prompted us to investigate whether
striatal subregion-specific structural changes could be responsible
for the DA release deficits. We performed electron microscopy
(EM) analysis of DA axons identified by TH immunogold
labeling in the dorsolateral striatum or NAc core. DA neuron
axons arborize extensively in the striatum, releasing DA at both
synaptic and non-synaptic sites38–40. We found that the majority
of TH+ axon profiles were non-synaptic, defined by the lack of a
discernable synaptic membrane specialization (Fig. 6a–d). The
proportion of axon profiles that formed synapses was similar
between genotypes (Supplementary Fig. 3a–e and Supplementary
Tables 3 and 4). Both synaptic and non-synaptic axon profiles
were included in the main analysis. Supplementary Tables 3 and 4
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provide full EM results including separate analyses of axon pro-
files forming synapses.
Consistent with the somatodendritic hypertrophy of SNc
neurons (see Fig. 1), TH+ axonal profile perimeter and area
were significantly increased in the dorsal striatum of DA-Tsc1-
KO mice (Fig. 6e, f). However, the TH+ axon profiles in the
NAc, which mainly arise from VTA neurons41, were not strongly
impacted (Fig. 6g, h). We quantified the number of vesicles
associated with each axon profile and found that vesicle number
was significantly decreased in DA-Tsc1-KO profiles in the dorsal
striatum, leading to a large reduction in vesicle density (Fig. 6i, j).
By contrast, vesicle number in axon profiles in the NAc was
slightly increased in DA-Tsc1-KO mice (Fig. 6k), and there was
no significant change in vesicle density between genotypes
(Fig. 6l).
To determine the spatial arrangement of vesicles within the
axonal profile, we measured the shortest distance of each vesicle
to the plasma membrane, and the distance of each vesicle to every
other vesicle within the profile (Supplementary Fig. 3f). The
average vesicle distance to the plasma membrane and inter-vesicle
distance within each profile were significantly increased in DA-
Tsc1-KO mice in both the dorsal striatum and NAc, but the
effects were more pronounced in the dorsal striatum (Fig. 6m–p).
When plotted as a histogram, the distribution of inter-vesicle
distances was shifted to the right for DA-Tsc1-KO profiles, with a
significant interaction between genotype and inter-vesicle dis-
tance found only for dorsal striatal terminals (Supplementary
Fig. 3g, h).
Taken together, the EM analyses revealed profound axon
profile hypertrophy and reduced vesicle density and clustering in
the dorsal striatum of DA-Tsc1-KO mice. Since the TH+ axon
profiles in the NAc from the same DA-Tsc1-KO mice were either
not significantly changed or only modestly affected, it is likely
that these selective changes in axonal architecture underpin the
observed striatal region-specific deficits in DA release (see Fig. 3).
Motor and social behaviors are unaffected in DA-Tsc1-KO
mice. DA is involved in a variety of behaviors, from movement to
reward learning to cognition18–21. To determine how the cellular
changes described above impact behavior in DA-Tsc1-KO mice,
we performed assays that are sensitive to dopaminergic function
and relevant to TAND. Supplementary Table 5 reports all beha-
vior results and Supplementary Table 6 shows behavioral analysis
by sex.
To examine locomotor activity, we tested animals in the open
field (Supplementary Fig. 4a). Deletion of Tsc1 did not affect
exploratory locomotor behavior, measured as the distance
traveled in the first 10 min (DA-Tsc1 WT: 24.55 ± 1.84 m, DA-
Tsc1 KO: 23.02 ± 1.49 m, p= 0.5153, unpaired, two-tailed t test).
The total distance traveled over 60 min and the mean speed were
also similar between genotypes (Supplementary Fig. 4b, c). We
observed no changes in rearing behavior or time spent grooming
(Supplementary Fig. 4d, e). Additionally, home cage locomotor
activity (Supplementary Fig. 4h–k) and spontaneous stereotypies
were not strongly impacted by Tsc1 loss (Supplementary Tables 5
and 6).
To test whether motor coordination or motor learning were
altered in DA-Tsc1-KO mice, we performed the accelerating
rotarod test42 (Supplementary Fig. 4l, m). We found no
significant differences in either initial motor coordination (DA-
Tsc1 WT 10.55 ± 1.19 r.p.m., DA-Tsc1 KO 13.37 ± 1.39 r.p.m.,
p= 0.2904, Mann–Whitney test, both sexes combined) or motor
learning (DA-Tsc1 WT 1.92 ± 0.25 r.p.m. per day, DA-Tsc1 KO
1.32 ± 0.19 r.p.m. per day, p= 0.0637, unpaired t test, both sexes
combined). Together, these results indicate that general locomo-
tor behaviors were unaffected by DA neuron-specific loss of Tsc1.
DA signaling modulates affective behaviors including anxiety
and sociability43,44, which can be impacted in patients with
TSC17,45. To measure avoidance behavior, we tested mice in the
elevated plus maze and found no significant difference in the
number of entries into or time spent in the open or closed arms
(Supplementary Fig. 4n–q). We did, however, find a small but
significant decrease in the time spent in the center of the open
field in male DA-Tsc1-KO mice, which indicates greater
avoidance behavior (Supplementary Fig. 4g). Social approach
was normal in DA-Tsc1-KO mice as assessed by the three-
chamber test (Supplementary Fig. 4r, s). Since these behaviors are
largely mediated by mesolimbic DA circuits arising from the
VTA43,44, the lack of major changes may reflect the relative
sparing of NAc DA release in DA-Tsc1-KO mice (see Fig. 3).
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DA-Tsc1-KO mice exhibit reduced cognitive flexibility. Cog-
nitive flexibility is commonly disrupted in TSC17 and in several
neuropsychiatric conditions including ASD and ADHD18,46,47.
Dorsal striatal DA signaling has been implicated in cognitive
flexibility48,49, and decreased striatal DA is associated with
reduced cognitive performance50–52. We therefore hypothesized
that loss of Tsc1 from DA neurons may disrupt cognitive flex-
ibility. To examine associative learning and cognitive flexibility, we
used the four-choice odor-based reversal task (Fig. 7a)53, in which
reversal learning is sensitive to changes in DA neuron function54.
We found that male DA-Tsc1-KO mice exhibited intact acquisi-
tion learning, reaching criterion in a similar number of trials
(Fig. 7b) and making, on average, the same number of errors as
littermate controls (Fig. 7c). Plots of the cumulative rewards
received by individual mice across trials showed that the genotypes
were overlapping (Fig. 7d). By contrast, when the rewarded odor
was changed the following day, DA-Tsc1-KO mice took, on
average, significantly longer to reach criterion and made more
total errors (Fig. 7e, f). The time course of cumulative rewards
during reversal learning shows that half of the DA-Tsc1-KO mice
went more than 20 trials before earning a reward, while all DA-
Tsc1-WT mice had received a reward by trial 20 (Fig. 7g). For
both genotypes, the majority of errors were perseverative (Fig. 7h),
meaning that the mice continued to choose the initially learned
odor even when it was no longer rewarded. However, DA-Tsc1-
KO mice made significantly more perseverative errors than WT
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littermates (Fig. 7h). Thus, DA-Tsc1-KO mice exhibited a selective
deficit in cognitive flexibility characterized by perseveration,
wherein they were slower to update their behavioral strategy in the
face of changed environmental demands.
It is unlikely that these findings were due to alterations in odor
preference or sensitivity as mice of both genotypes showed similar
spontaneous odor preference in the first four trials of acquisition
learning and could clearly discriminate between the four odors
prior to making a digging choice. Differences in hunger status or
motivation were also unlikely as both groups consumed a similar
number of total rewards during acquisition and reversal (Fig. 7i).
Additionally, during reversal learning, once the DA-Tsc1-KO
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mice made their first correct odor choice, they took a similar
number of trials to reach criterion as DA-Tsc1-WT mice (Fig. 7j).
These data indicate that perseveration to choose the initially
rewarded odor at the expense of exploring other odors was the
main driver for the slower reversal learning in DA-Tsc1-KO mice.
This is further supported by plotting the average odor choices in
four trial bins during the first 16 trials of reversal learning
(Fig. 7k). This analysis shows that DA-Tsc1-KO mice continue to
choose the initially rewarded odor for longer, while DA-Tsc1-WT
mice are faster to switch their odor choice. Together, these results
demonstrate that loss of Tsc1 from DA neurons is sufficient to
increase perseveration and reduce cognitive flexibility in mice.
Systemic rapamycin does not suppress mTORC1 in DA neu-
rons. To test whether phenotypes observed in DA-Tsc1-KO mice
could be rescued by pharmacologic inhibition of mTOR signaling,
we treated mice chronically with rapamycin (8 mg/kg per day,
3 days a week) for 2 months starting at 4 weeks of age. We
quantified p-S6 levels as a read-out of mTORC1 signaling, and
found, surprisingly, that rapamycin treatment did not reduce p-
S6 levels in DA neurons compared to vehicle in either DA-Tsc1-
WT or DA-Tsc1-KO mice (Supplementary Fig. 5). Importantly,
however, when we analyzed hippocampal and cerebellar neurons
from the same mice, we found the expected decrease in p-S6
levels after rapamycin treatment (Supplementary Fig. 6), con-
sistent with prior studies7,13. This demonstrates that systemic
rapamycin has differential effects depending on the cell type and
suggests that chronic rapamycin may not be an effective treat-
ment to decrease mTORC1 signaling and ameliorate phenotypic
changes in DA neurons after Tsc1 loss.
Genetic reduction of Rptor constrains mTORC1 signaling. To
overcome the caveats of systemic rapamycin, we tested whether
phenotypes in DA-Tsc1-KO mice could be prevented by cell type-
specific genetic manipulation of mTORC1 signaling. To do this,
we conditionally deleted one or two copies of the Rptor gene
encoding the mTOR-binding protein Raptor in DA-Tsc1-KO
mice to constrain mTORC1 signaling (Fig. 8a, b and Supple-
mentary Fig. 7a). Raptor is an obligate member of mTORC1 and
deletion of Rptor leads to selective mTORC1 loss of function55,56.
This cell type-specific genetic strategy has two advantages over
systemic pharmacologic suppression of mTOR: (1) manipulation
of mTORC1 is restricted to DA neurons, and (2) mTORC1
activity can be selectively altered, without disrupting mTORC2.
We found that homozygous deletion of Rptor from DA-Tsc1-
KO mice completely suppressed mTORC1 activity in DA
neurons, as shown by the lack of p-S6 immunostaining
(Supplementary Fig. 7b–f). DA neuron soma size was significantly
smaller in DA-Tsc1-KO/Rptor-KO mice, and TH levels were
reduced (Supplementary Fig. 7g, h). However, complete loss of
Raptor was not able to rescue the dorsal striatal DA release
deficits (Supplementary Fig. 7i–l). This may be a result of
impaired DA synthesis, given the reduced TH levels. These results
demonstrate that overactivation or complete suppression of
mTORC1 are similarly detrimental to striatal DA transmission.
We next tested whether reduction, rather than complete
suppression, of mTORC1 could prevent phenotypes in DA-
Tsc1-KO mice. To do this, we compared DA-Tsc1-KO mice that
were either wild-type or heterozygous (Het) for the conditional
Rptor allele (Fig. 8b). Consistent with a reduction in mTORC1-
signaling, p-S6 and TH levels in SNc neurons were significantly
reduced in DA-Tsc1-KO/Rptor-Het mice compared to DA-Tsc1-
KO/Rptor-WT (Fig. 8c–h). However, heterozygous deletion of
Rptor did not prevent the increased soma size due to loss of Tsc1
(Fig. 8i). Therefore, heterozygous Rptor deletion constrained
mTORC1 signaling in DA neurons in the context of Tsc1 loss, but
was not sufficient to prevent somatic hypertrophy.
Heterozygous Rptor deletion restores cognitive flexibility. To
test whether the DA release deficits in DA-Tsc1-KO mice could
be prevented by genetic reduction of mTORC1 signaling, we
performed FCV experiments and found that DA-Tsc1-KO/Rptor-
Het slices had significantly higher evoked [DA]o throughout the
dorsal striatum compared to DA-Tsc1-KO/Rptor-WT slices
(Fig. 8j–m). Notably, DA release levels in DA-Tsc1-KO/Rptor-
Het slices were comparable to levels in WT slices (Supplementary
Fig. 8). We measured the 4p/1p ratio and found that DA-Tsc1-
KO/Rptor-Het slices had reduced 4p/1p ratio compared to DA-
Tsc1-KO/Rptor-WT slices, indicating higher Pr (Fig. 8n). Taken
together, these results demonstrate that heterozygous Rptor
deletion successfully relieved DA release deficits in the context of
Tsc1 loss.
Given the functional improvements in DA release, we tested
whether DA-Tsc1-KO/Rptor-Het mice had increased cognitive
flexibility in the four-choice reversal learning task (Fig. 9a). We
observed no differences between male littermate DA-Tsc1-KO/
Rptor-Het and DA-Tsc1-KO/Rptor-WT mice in acquisition
learning (Fig. 9b–d). However, during reversal learning, DA-
Tsc1-KO/Rptor-Het animals reached criterion in significantly
fewer trials, made fewer total errors, and made fewer persevera-
tive errors specifically (Fig. 9e–h). As discussed above for Fig. 7,
these results are unlikely to be driven by major changes in odor
preference or motivation (Fig. 9i, j). Plotting the odor choices
across the first 16 trials of reversal learning showed that the DA-
Tsc1-KO/Rptor-Het mice were faster to switch their odor choice
(Fig. 9k). Together, these data demonstrate that cell type-specific
genetic reduction of mTORC1 signaling in DA-Tsc1-KO mice
improves evoked DA release and cognitive flexibility.
Discussion
In this study, we used a cell type-targeted approach to investigate
how loss of Tsc1 and deregulation of mTORC1 affect the dopa-
minergic system. We found that deletion of Tsc1 from DA neu-
rons strongly impacted their properties leading to somatodendritic
and axonal hypertrophy, reduced intrinsic excitability, and
impaired striatal DA release. These cellular changes were sufficient
to reduce cognitive flexibility in a reversal learning task. We
showed that DA release deficits and cognitive inflexibility in DA-
Tsc1-KO mice could be prevented by genetic reduction of
mTORC1 signaling. Together, these data provide insight into the
Fig. 6 Loss of Tsc1 alters DA axon ultrastructure. a–d Example electron micrographs of dopaminergic axon profiles in the dorsolateral striatum (a, b) or
nucleus accumbens core (c, d) of DA-Tsc1-WT (a, c) and DA-Tsc1-KO (b, d) mice, identified by enriched immunogold labeling for tyrosine hydroxylase
(TH), scale bars= 0.2 μm. Right panels show TH+ axon profiles pseudocolored in blue (DA-Tsc1 WT) or red (DA-Tsc1 KO). e–p Cumulative distributions
of TH+ axon profile perimeter (e, g), profile area (f, h), number of vesicles per profile (i, k), vesicle density (j, l), vesicle distance to plasma
membrane (m, o), and inter-vesicle distance (n, p). p Values for Kolmogorov–Smirnov tests are shown. For e, f, i, j, m, n: DA-Tsc1 WT, n= 239 terminals
(synaptic and non-synaptic) from four mice; DA-Tsc1 KO, n= 252 terminals from four mice. For g, h, k, l, o, p: n= 120 terminals (synaptic and non-
synaptic) from four mice per genotype. Source data are provided as a Source Data file.
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potential cellular origins of cognitive inflexibility in TSC, and
suggest a locus for possible intervention.
Several prior studies have assessed the consequences of deletion
of the mTORC1-negative regulator Pten on DA neurons. Similar
to loss of Tsc1, selective deletion of Pten from DA neurons causes
somatodendritic hypertrophy, increased TH expression, and
elevated total DA tissue content in the absence of changes to gross
motor behavior57–59. However, distinct from Pten deletion59, we
find that loss of Tsc1 is sufficient to dramatically increase DA
axon terminal size in the dorsal striatum. Since we observed
region-specific effects of Tsc1 loss on DA terminals, the differ-
ences may be due to the striatal region sampled for EM in prior
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studies, or may reflect distinct biological consequences of Pten
versus Tsc1 deletion. One notable difference is that Pten deletion
increases both Akt and mTORC1 signaling58,59, whereas deletion
of Tsc1 activates mTORC1 but suppresses Akt phosphorylation5.
Our findings also show some similarities with prior work that
deleted the macroautophagy regulator Atg7 from DA neurons.
One of the key consequences of increased mTORC1 signaling is
autophagy suppression60. Therefore, some of the Tsc1 phenotypes
may result from impaired autophagy. Consistent with this, DA
neuron-specific Atg7-KO mice also display increased soma size
and axon terminal area61, suggesting that these phenotypes in DA-
Tsc1-KO mice could be due to dysfunctional macroautophagy.
That said, DA-Atg7-KO mice have increased striatal DA release
and DA turnover59,61, which were not observed in DA-Tsc1-KO
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mice. Thus, while autophagy may be one downstream mechanism
governing a subset of phenotypes in DA-Tsc1-KO neurons, there
are likely additional cellular pathways that contribute to the
overall complex phenotype resulting from Tsc1 loss.
We found that constitutive activation of mTORC1 signaling
profoundly affected DA neuron structure and significantly
impaired striatal DA release. This deficit was present in young
adult mice and stably persisted in aged animals. We attempted to
reverse these alterations with the widely used mTOR inhibitor
rapamycin. However, we found unexpectedly that chronic sys-
temic rapamycin treatment did not reduce p-S6 levels in DA
neurons in either DA-Tsc1-WT or DA-Tsc1-KO mice. Since this
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lack of change was specific to DA neurons, with other brain
regions showing the expected reduction in p-S6, we hypothesize
that this could be due to two possibilities: (1) there is differential
brain penetration of rapamycin, with midbrain DA neurons
receiving lower effective concentrations and/or (2) there may be
cell type-specific responses to systemic metabolic changes
induced by rapamycin. For example, it is known that chronic
rapamycin induces metabolic side effects, including glucose
intolerance, fasting hyperglycemia and hyperinsulinemia due to
actions on the liver and pancreas62. Regardless of the mechanism,
these findings raise important caveats about the use of systemic
rapamycin to treat the spectrum of neuropsychiatric phenotypes
in TSC. We speculate that our findings provide a potential
explanation for the failure of rapamycin derivatives to improve
cognitive deficits in recent clinical trials in TSC63,64.
Given the challenges of systemic pharmacology, we utilized a
genetic approach in which we selectively decreased
mTORC1 signaling via deletion of the gene encoding the obligate
mTORC1 protein Raptor in DA-Tsc1-KO mice. In addition to
being cell type specific, this strategy avoids manipulation of
mTORC2 signaling, which is known to occur with prolonged
rapamycin treatment65. Interestingly, when we completely sup-
pressed mTORC1 with homozygous deletion of Rptor, we found
similar deficits in evoked DA release as with Tsc1 deletion alone.
The failure of complete mTORC1 suppression to prevent release
deficits is consistent with prior reports showing that acute
treatment of striatal slices with rapamycin or Cre virus-mediated
deletion of mTOR from VTA neurons both decrease evoked DA
release61,66. By contrast, we found that heterozygous loss of Rptor
in DA-Tsc1-KO mice, while not sufficient to prevent somatic
hypertrophy, significantly improved striatal DA release and
countered reduced cognitive flexibility. Together, these results
indicate that tight regulation of mTORC1 signaling is essential for
DA neuron output as too much or too little mTORC1 signaling is
similarly detrimental. In addition, our findings show that changes
in DA neuron soma size can be decoupled from alterations in
axonal DA release.
After ruling out several potential mechanisms for the release
impairments in DA-Tsc1-KO mice, including DA neuron
death, striatal denervation, and reduced DA synthesis, the most
plausible explanation was ultrastructural changes in DA neu-
ron axons. Specifically, we found that Tsc1 loss resulted in
highly enlarged TH+ axon terminals and reduced vesicle
density in the striatum. In addition, the vesicles were further
removed from the plasma membrane and were less tightly
clustered together. Notably, axonal changes in the dorsal
striatum, which is primarily innervated by SNc neurons, were
much more pronounced than those in the NAc, which receives
mainly VTA input. Given the stringent structural requirements
for efficient vesicle release, for example, vesicle proximity to
docking sites67 and vesicle clustering68, it is likely that the
observed ultrastructural changes in DA-Tsc1 KO axons led to
impaired dorsal striatal DA release with a relative sparing of
NAc DA release.
Cognitive flexibility is commonly affected in psychiatric dis-
orders, in particular ASD and ADHD46,47,69. TSC patients fre-
quently present with impairments in executive control processes,
which include cognitive flexibility17,45. Here, we found that DA
neuron-specific deletion of Tsc1 was sufficient to reduce cognitive
flexibility in a reversal learning task. This reduction was specific
to reversal learning as initial discrimination learning was intact.
Notably, during reversal learning, DA-Tsc1-KO mice made more
perseverative errors, in which they continued to return to the
previously learned odor even though it was no longer rewarded.
Perseverative errors reflect an inability to flexibly adapt and
update a previously learned association. Such a deficit may
contribute to the inflexible behaviors often observed in indivi-
duals with TSC17.
Our findings are consistent with prior reports showing that
brain-wide heterozygous deletion of Tsc2 or disruption of the
translational regulator eIF4E, which increases protein synthesis,
impair reversal but not acquisition learning in water maze
tasks70,71. Our work suggests that these types of impairments may
result from dopaminergic dysfunction; an interpretation con-
sistent with the known involvement of DA in cognitive flexibility
in rodents and humans18,49. Our results are also in agreement
with studies showing that moderate reductions in dorsal striatal
DA levels in rats can impair cognitive flexibility without changing
motor behavior72,73. While our study demonstrates the suffi-
ciency of dopaminergic impairments to induce cognitive inflex-
ibility, alterations in other brain regions, including the
cerebellum13, may also contribute to this complex phenotype in
the context of TSC.
Methods
Mice. All animal procedures were carried out in accordance with protocols
approved by the University of California, Berkeley Institutional Animal Care and
Use Committee (IACUC). The ages of the animals used are indicated in the
Method Details for each experiment. Unless otherwise indicated, mice of both sexes
were used. Mice were an outbred strain on mixed genetic background as deter-
mined by the Charles River Mouse 384 SNP Complete Background Analysis Panel,
with average percent heterozygosity of 22.9% (13.1–33.7% range). Mice were
housed with same-sex littermates in groups of 5–6 animals per cage and kept on a
regular 12 h light/dark cycle (lights on at 7:00 a.m.), with ad libitum access to food
and water. Animals in behavior experiments were housed in a facility with a reverse
12 h light/dark cycle (lights off at 9:00 a.m.). Mice were switched to the reverse light
cycle at least 2 weeks prior to behavior testing and were tested during the
dark phase.
Breeding strategy. To generate DA neuron-specific Tsc1-KO mice, Tsc1fl/fl mice
were bred to DATIRESCrewt/+ mice. To generate experimental animals, mice het-
erozygous for floxed Tsc1 and DATIRESCre were crossed (Tsc1wt/fl;DATIRESCrewt/+ ×
Tsc1wt/fl;DATIRESCrewt/+). Experimental mice were heterozygous for Cre and either
homozygous WT for Tsc1 (Tsc1wt/wt;DATIRESCrewt/+, referred to as DA-Tsc1-WT)
or homozygous floxed for Tsc1 (Tsc1fl/fl; DATIRESCrewt/+, referred to as DA-Tsc1-
KO).
For electrophysiology experiments, Tsc1fl/fl;DATIRESCrewt/+ mice were bred to
the Ai9 tdTomato Cre-reporter line. Tsc1wt/fl;DATIRESCrewt/+;Ai9wt/+ × Tsc1wt/fl;
DATIRESCrewt/+;Ai9wt/+ crosses were used to generate experimental mice. Mice
used for experiments were either heterozygous or homozygous for the Ai9
transgene.
For genetic rescue experiments, Tsc1fl/fl;DATIRESCrewt/+mice were crossed with
Rptorfl/fl mice. To generate experimental animals, a Tsc1fl/fl;Rptorwt/fl;
DATIRESCrewt/+ × Tsc1fl/fl;Rptorwt/fl;DATIRESCrewt/+ breeding strategy was used.
The resulting offspring were all homozygous floxed for Tsc1 and either wild type
(Tsc1fl/fl;Rptorwt/wt;DATIRESCrewt/+, referred to as DA-Tsc1-KO/Rptor-WT),
heterozygous (Tsc1fl/fl;Rptorwt/fl;DATIRESCrewt/+, referred to as DA-Tsc1-KO/
Rptor-Het), or homozygous floxed (Tsc1fl/fl;Rptorfl/fl;DATIRESCrewt/+, referred to as
DA-Tsc1-KO/Rptor-KO) for Rptor.
To compare Tsc1fl/fl;Rptorwt/fl;DATIRESCrewt/+ mice with Tsc1wt/wt;Rptorwt/wt;
DATIRESCrewt/+ mice, a Tsc1wt/fl;Rptorwt/fl;DATIRESCrewt/+ × Tsc1wt/fl;Rptorwt/fl;
DATIRESCrewt/+ cross was made. Offspring wild type for Tsc1 and Rptor (Tsc1wt/wt;
Rptorwt/wt;DATIRESCrewt/+, referred to as DA-Tsc1-WT/Rptor-WT) were
compared to DA-Tsc1-KO/Rptor-Het (Tsc1fl/fl;Rptorwt/fl;DATIRESCrewt/+, referred
to as DA-Tsc1-KO/Rptor-Het) animals.
See Supplementary Table 7 for a list of the transgenic mouse lines used and
Supplementary Table 8 for a list of mouse genotyping primers.
Electrophysiology. Male and female adult mice (P56–P80) were deeply anesthe-
tized by isoflurane, transcardially perfused with ice-cold high Mg2+ artificial cer-
ebrospinal fluid (aCSF) using a peristaltic pump (Instech) and decapitated. Coronal
midbrain slices (275 μm thick) were prepared on a vibratome (Leica VT1000 S) in
ice-cold high Mg2+ aCSF containing (in mM): 85 NaCl, 25 NaHCO3, 2.5 KCl, 1.25
NaH2PO4, 0.5 CaCl2, 7 MgCl2, 10 glucose, and 65 sucrose. Slices were recovered for
15 min at 34 °C, followed by at least 50 min at room temperature (RT) in aCSF
containing (in mM): 130 NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2,
2 MgCl2, and 10 glucose. All solutions were continuously bubbled with 95% O2 and
5% CO2.
Recordings were performed at 32 °C in the presence of AMPA (α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid), NMDA (N-methyl-D-aspartate), and
GABAA (type A γ-aminobutyric acid) synaptic blockers (10 μM GYKI 52466;
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10 μM CPP; 50 μM picrotoxin, final concentration, all from Tocris), with a bath
perfusion rate of ~2 ml/min. Dopaminergic neurons in the SNc and VTA were
identified by Ai9 tdTomato fluorescence. For whole-cell recordings, 2.5–6 mΩ
borosilicate glass pipettes (Sutter Instruments: BF150-86-7.5) were filled with a
potassium-based internal solution containing (in mM): 135 KMeSO3, 5 KCl, 5
HEPES, 4 Mg-ATP, 0.3 Na-GTP, 10 phospho-creatine, 1 EGTA, and 4 mg/ml
neurobiotin (Vector Laboratories #SP-1120). Recordings were obtained using a
MultiClamp 700B amplifier (Molecular Devices) and ScanImage software (https://
github.com/bernardosabatini/SabalabAcq). Passive membrane properties were
recorded in voltage clamp with the membrane held at −70 mV. Negative current
steps (2 s, −50 to −200 pA) were applied to measure the sag amplitude and
rebound following hyperpolarization. Positive current steps (2 s, +25 to +600 pA)
were applied to generate an input–output curve from a baseline membrane
potential of −70 mV as maintained by current clamp. For whole-cell recordings,
series resistance was <30MΩ and liquid junction potential was not corrected.
Electrophysiology data were acquired using the ScanImage software, written
and maintained by Dr. Bernardo Sabatini (https://github.com/bernardosabatini/
SabalabAcq). Data were analyzed in Igor Pro (Wavemetrics). Evoked AP properties
were measured from the first AP in the train of evoked APs. AP threshold was
calculated by taking the second derivative of the AP. AP duration was measured at
the half-maximal membrane potential. Rheobase was calculated as the current at
which APs were first elicited. Passive properties were calculated from an RC check
in voltage clamp recordings at −70 mV. Passive properties and AP properties were
analyzed for significance using two-tailed unpaired t tests, Mann–Whitney tests, or
t tests with Welch’s correction. Excitability curves were analyzed for significance
using a two-way analysis of variance (ANOVA) with Sidak’s multiple
comparison tests.
Neurobiotin-filled neuron reconstruction. DA neurons were filled with
neurobiotin-containing internal solution (4mg/ml) during whole-cell recordings.
Slices were fixed in 4% paraformaldehyde solution (Electron Microscopy Sciences:
15713) in 1× phosphate-buffered saline (PBS) for 24–48 h at 4 °C. With continuous
gentle shaking, slices were washed in 1× PBS 3 × 5min and incubated with BlockAid
blocking solution (Life Tech: B10710) for 1 h at room temperature (RT). Primary
antibodies against TH (1:1000, Immunostar: 22941) and streptavidin–Alexa Flour
488 conjugate (1:750, Invitrogen: S11223) were applied overnight at 4 °C in 1× PBS
containing 0.25% Triton X-100 (PBS-Tx). The following day, slices were washed in
1× PBS 3 × 5min, and secondary Alexa-633 goat anti-mouse antibody (1:500,
Thermo Fisher: A21050) in PBS-Tx was applied for 1 h at RT. Slices were washed in
cold 1× PBS 5 × 5min, mounted on SuperFrost slides (VWR: 48311-703) with the
neurobiotin-filled cell facing up, and coverslipped with either Prolong Gold antifade
(Life Tech: P36935) or Vectashield hard-set (Vector Labs: H-1500) mounting media.
Neurobiotin-labeled cells were imaged on a Zeiss LSM 880 NLO AxioExaminer
confocal with ×20/1.0 NA water-immersion objective and 488 Argon laser using
1.53 µm steps to acquire a z-stack image spanning the entirety of the neurobiotin-
filled cell body and dendritic arbor. 3D reconstruction of the cells was performed
using the IMARIS software (Bitplane) with automated filament tracing and manual
editing. The mask generated by the automated filament tracing algorithm was
continuously cross-referenced with the original z-stack image to ensure accuracy.
Spurious segments created by the automated filament tracer were removed, while
processes with incomplete reconstruction were edited to incorporate missing
segments. Sholl analysis of dendritic arborization was performed by quantifying the
number of intersections of dendrites with concentric circles drawn at 1 µm steps,
starting 7 µm from the center point of the soma.
Total dendrite length was analyzed using an unpaired t test and Sholl
intersections were analyzed using a repeated-measures two-way ANOVA.
Fast-scan cyclic voltammetry (FCV). DA release was monitored using FCV in
acute coronal slices36,74,75. Paired site-sampling interleaved recordings were per-
formed in slices from one reference and one experimental animal in a sex- and age-
matched mouse pair recorded on the same day using the same carbon fiber
microelectrode (CFM). The genotype order of tissue prep was counterbalanced
between experiments. Male and female mice (P56-P95 or P660-725) were deeply
anesthetized by isoflurane and decapitated. 275 μm thick coronal striatal slices were
prepared on a vibratome (Leica VT1000 S) in ice-cold high Mg2+ ACSF containing
in mM: 85 NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 0.5 CaCl2, 7 MgCl2, 10
glucose, and 65 sucrose. Slices were recovered for 1 h at RT and were recorded from
in ACSF containing in mM: 130 NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2
CaCl2, 2 MgCl2, and 10 glucose. All solutions were continuously saturated with
95% O2 and 5% CO2. Slices between +1.5 mm and +0.5 mm from Bregma con-
taining dorsal striatum and NaC (ventral striatum) were used for
experimentation76.
In the recording chamber, slices were maintained at 32 °C with a superfusion
rate of 1.2–1.4 ml/min. Extracellular DA concentration ([DA]o) was monitored
with FCV at CFMs using a Millar voltammeter (Julian Millar, Barts and the
London School of Medicine and Dentistry). CFMs were fabricated in-house from
epoxy-free carbon fiber ~7 μm in diameter (Goodfellow Cambridge Ltd) encased in
a glass capillary (Harvard Apparatus: GC200F-10) pulled to form a seal with the
fiber and cut to a final tip length of 70–120 μm. The CFM was positioned ~100 μm
below the tissue surface at a 45° angle. A triangular waveform was applied to the
carbon fiber scanning from −0.7 to +1.3 V and back, against a Ag/AgCl reference
electrode at a rate of 800 V/s. Evoked DA transients were sampled at 8 Hz, and data
were acquired at 50 kHz using AxoScope 10.5 (Molecular Devices). Oxidation
currents evoked by electrical stimulation were converted to [DA]o from post-
experimental calibrations of the CFM. Recorded FCV signals were identified as DA
by comparing oxidation (+0.6 V) and reduction (−0.2 V) potential peaks from
experimental voltammograms with currents recorded during calibration with 2 μM
DA dissolved in aCSF and all drug-containing media used in a given experiment.
FCV data were pre-processed using the AxoScope 10.5 (Molecular Devices)
software and analyzed using Excel. Within a given experiment, quinpirole data
were normalized to control drug-free data, frequency data were normalized to
single pulses, and current-amplitude data were normalized to 1200 μA current data,
before collating across experiments. We included a minimum of three release
events for each stimulus or condition at each individual recording site for these
experiments. Quinpirole effects were compared using sigmoidal curve-fit analyses.
Current-amplitude and frequency-response data were compared using a two-way
ANOVA with Sidak’s multiple comparisons tests.
For all site-sampling experiments (aCSF, DHβE, oxo-M, 5 mM Ca2+) single
pulse and four pulses at 100-Hz-evoked DA concentrations were compared without
normalization because control and experimental slices were recorded with the same
CFM for every experimental pair. A minimum of four matched mouse pairs were
used in these experiments, with two slices per animal recorded from. Single-pulse
data includes two release events per site per slice, and pulse train data includes one
release event per site per slice. Peak-evoked DA release levels were compared
between genotypes using paired t test tests or Wilcoxon’s t tests.
Extracellular DA uptake is exponentially related to the substrate concentration
and DAT expression can vary by striatal region32,40. To meaningfully compare
DAT kinetics, we identified concentration- and striatal region-matched transients
from DA-Tsc1-WT and DA-Tsc1-KO slices and examined their decay kinetics
using one-phase exponential decay curve-fit analyses. Only the data from single-
pulse stimulations were used for these analyses.
FCV electrical stimulation and drug application. Following 30 min slice equili-
bration in the recording chamber, DA release was evoked using square wave pulses
(0.6 mA pulse amplitude, 2 ms pulse duration) controlled by a Master-8 pulse
stimulator or Isoflex stimulus isolator (A.M.P.I., Jerusalem, Israel) delivered out of
phase with voltammetric scans. A concentric bipolar stimulating electrode (FHC:
CBAEC75) used for electrical stimulation was positioned on the slice surface first
with minimal tissue disturbance, followed by CFM inserted 100 μm away from the
bipolar electrode. Three stimulation paradigms were used: single stimulation pulse,
paired single pulses delivered 3 s apart, and brief four-pulse stimulation trains
delivered at 5, 10, 25, 40, or 100 Hz. Stimuli were delivered every 2.5 min.
For site-sampling experiments, three stimulations were delivered at a given site
before moving to the corresponding site in the slice from the paired mouse.
Stimulations were delivered in the following order: single pulse, pulse train of four
pulses at 100 Hz, single pulse. The sampling sites were: (1) dorsolateral striatum,
(2) dorsocentral striatum, (3) dorsomedial striatum, (4) central striatum, (5)
ventrolateral striatum, (6) ventromedial striatum, and (7) NAc core (two sampling
sites within the core were averaged together for quantification).
For quinpirole experiments, recordings were performed from a single site per
slice. After reaching a steady baseline release with single pulses in control aCSF,
increasing doses of quinpirole (1 nM–10 µM, Tocris) were bath-applied for
~10 min each, with steady-state release achieved for at least four consecutive
stimulations before progression to the next highest drug concentration. Traces are
peak normalized to control values prior to drug application within each genotype
for quantification.
For current-amplitude and frequency-response recordings, recordings were
performed from a single site per slice. After reaching a steady baseline release with
single pulses, each stimulation condition was repeated three times at each
frequency/current amplitude in a pseudorandom order.
Immunohistochemistry. Male and female mice (P75–P120) were deeply anes-
thetized by isoflurane and exsanguinated by transcardial perfusion with ice-cold 1×
PBS (~5–7 ml), followed by 4% paraformaldehyde (PFA) solution (Electron
Microscopy Sciences: 15713) in 1× PBS (~5–10 ml) using a peristaltic pump
(Instech). The brains were removed and post fixed by immersion in 4% PFA in 1×
PBS overnight at 4 °C. Brains were then suspended in 30% sucrose in 0.1 M PB
solution for cryoprotection. After brains descended to the bottom of the vial
(typically 24–28 h), 30 μm coronal sections of the midbrain or striatum were cut on
a freezing microtome (American Optical AO 860), collected into serial wells, and
stored at 4 °C in 1× PBS containing 0.02% (w/v) sodium azide (NaN3; Sigma-
Aldrich).
Free-floating brain sections for immunohistochemistry were batch processed to
include matched control and experimental animals. With gentle shaking, sections
were washed 3 × 5min in 1× PBS, followed by 1 h incubation at RT with BlockAid
blocking solution (Life Tech: B10710). Primary antibodies were applied at 4 °C in
PBS-Tx for 48–72 h. Sections were washed with cold 1× PBS 3 × 5 min, incubated
for 1 h at RT with secondary antibodies in PBS-Tx, washed in cold 1× PBS 5 ×
5 min, mounted on SuperFrost slides (VWR: 48311-703), and coverslipped with
Vectashield hard-set (Vector Labs: H-1500) mounting media. For DA neuron
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count experiments, slices underwent no additional processing apart from 1× PBS
wash 5 × 5min. Experimenters were blind to animals’ genotype throughout tissue
processing and data analysis. See Supplementary Table 9 for a list of antibodies
used for immunohistochemistry.
Confocal microscopy. Images of brain sections were acquired using a Zeiss LSM
710 AxioObserver confocal microscope fitted with a motorized XY stage for tile
scanning. A ×20/0.8 NA air objective was used to generate tile scans (424 × 424 μm
per tile) of one hemisphere (5 × 3 grid) or the entire midbrain (10 × 3 grid). The
405 nm, 488 nm, 561 nm, and 633 nm lasers were used. Z-stack images captured
the entire thickness of the slice at 1.10–1.25 μm steps. Laser power settings and
acquisition parameters were kept constant for all experimental conditions.
Image analysis was performed blind to genotype. Quantification was performed
on max-projected z-stack images, two sections per mouse were analyzed and
averaged together. For soma size and p-S6 measurements, soma boundaries were
traced manually using the Image J (NIH) software in the TH channel to include all
clearly identifiable single cells in the SNc or VTA (minimum of 100 cells for each
area in each slice). Soma cross-sectional area and fluorescence intensity for the p-S6
channel were extracted automatically in Image J. Cumulative distributions were
analyzed using Kolmogorov–Smirnov tests (when comparing two groups) or the
Kruskal–Wallis test with Dunn’s multiple comparisons tests (when comparing four
groups).
For DA neuron counts, every clearly identifiable tdTomato+ cell in both
hemispheres in both the SNc and VTA was manually counted using the Cell
Counter Image J (NIH) plug-in, and analyzed using an unpaired t test. Three
anatomically matched sections in the rostro-caudal plane per mouse were counted
in three age- and sex-matched mouse pairs (i.e. nine sections were counted from
three mice per genotype).
High-performance liquid chromatography. Tissue DA content was measured by
HPLC with electrochemical detection in tissue punches from dorsal and ventral
striatum. Male and female mice (P60–P75) were deeply anesthetized by isoflurane
and decapitated. Coronal slices (300 μm thick) of striatum were prepared on a
vibratome (Leica VT1000 S) in ice-cold high Mg2+ aCSF containing (in mM): 85
NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 0.5 CaCl2, 7 MgCl2, 10 glucose, and
65 sucrose. Slices were recovered for 1 h at RT in aCSF containing (in mM): 130
NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, 2 MgCl2, and 10 glucose. All
solutions were continuously bubbled with 95% O2 and 5% CO2. Following slice
recovery, tissue punches from the dorsal striatum (2.5 mm diameter, aligned to the
edge of the corpus callosum on the dorsolateral side) and ventral striatum (1.5 mm
diameter, centered on the anterior commissure) from two brain slices per animal
were taken and stored at −80 °C in 200 µl of 0.1 M HClO4. Ventral striatum
samples hence included both NAc core and shell. On the day of analysis, samples
were thawed, homogenized, and centrifuged at 16,000 × g for 15 min at 4 °C. The
supernatant was analyzed for DA, DOPAC, and 5-hydroxyindoleacetic acid con-
tent using HPLC with electrochemical detection. Analytes were separated using a
4.6 × 150 mm2 Microsorb C18 reverse-phase column (Varian or Agilent) and
detected using a Decade II SDS electrochemical detector with a Glassy carbon
working electrode (Antec Leyden) set at +0.7 V with respect to a Ag/AgCl refer-
ence electrode. The mobile phase consisted of 13% methanol (v/v), 0.12M
NaH2PO4, 0.5 mM OSA (osanetant), 0.8 mM EDTA, pH 4.8, and the flow rate was
fixed at 1 ml/min. Analyte measurements were normalized to tissue punch volume
(pmol/mm3). HPLC data was collected with Clarity (DataApex, release version
2.6). HPLC analysis was repeated in two independent experiments.
Analysis was performed blind to genotype. Data were normalized and expressed
as a percent of control within a given experiment before collating across
experiments (samples were collected and analyzed in two batches). Two samples
were analyzed per mouse and averaged together. Data were analyzed for statistical
significance using a two-tailed unpaired t test.
Western blotting. Male and female mice (P60–P90) were deeply anesthetized by
isoflurane and decapitated. Bilateral striata, including both dorsal and ventral
regions, were rapidly dissected on ice, flash-frozen in liquid nitrogen, and stored at
−80 °C. On the day of analysis, frozen samples were sonicated until homogenized
(QSonica Q55) in 500 μl lysis buffer containing 1% SDS in 1× PBS with Halt
phosphatase inhibitor cocktail (Fisher: PI78420) and Complete mini EDTA-free
protease inhibitor cocktail (Roche: 4693159001). Sample homogenates were then
boiled on a heat block at 95 °C for 10 min, allowed to cool down to RT, and total
protein content was determined by BCA assay (Fisher: PI23227). Following BCA
assay, protein homogenates were mixed with 4× Laemmli sample buffer (Bio-Rad:
161-0747). Proteins (10–15 μg) were loaded onto 4–15% Criterion TGX gels (Bio-
Rad: 5671084). Proteins were transferred to PVDF membrane (Bio-Rad: 1620177)
at 4 °C overnight using the Bio-Rad Criterion Blotter (12 V constant voltage). The
membranes were blocked in 5% milk in 1× TBS with 1% Tween (TBS-T) for 1 h at
RT, and incubated with primary antibodies diluted in 5% milk in TBS-T overnight
at 4 °C. The following day, after 3 × 10 min washes with TBS-T, the membranes
were incubated with horseradish peroxidase-conjugated secondary antibodies for
1 h at RT. Following 6 × 10 min washes, the membranes were incubated with
chemiluminesence substrate (PerkinElmer: NEL105001EA) for 1 min and exposed
to GE Amersham Hyperfilm ECL (VWR: 95017-661). Membranes were stripped
with re-blot plus strong solution (Millipore: 2504) to re-blot on subsequent days.
Western blot analysis was performed blind to genotype. Bands were quantified
by densitometry using the Image J (NIH) software. The striatal-enriched protein
DARPP-32 was used to normalize striatal tissue content and histone 3 was used as
a loading control. Samples were taken from the whole striatum, including both
dorsal and ventral regions. Two striatum samples (i.e. left and right hemispheres)
were analyzed per mouse and averaged together. Once normalized to DARPP-32,
protein content was expressed as percentage of control within a given experiment.
TH data were analyzed using an unpaired t test with Welch’s correction and
VMAT-2 data were analyzed using a Mann–Whitney test. Uncropped western
blots are provided in the Source Data file. See Supplementary Table 10 for a list of
antibodies used for western blotting.
Sample preparation for EM. Male and female mice (P75–P85) were deeply
anesthetized by isoflurane, exsanguinated by transcardial perfusion with ice-cold
0.1 M PB (pH 7.4), followed by fixation with 0.1% glutaraldehyde (Sigma-Aldrich:
G5882) and 4% paraformaldehyde (Electron Microscopy Sciences: 15713) solution
in 0.1 M PB. Perfusions were performed using a peristaltic pump (Instech). The
brains were removed and immersed in the fixative solution for an additional 12 h at
4 °C. Brains were then stored in 0.1 M PB with 0.02% (w/v) NaN3. Coronal sections
(50 µm) containing dorsal striatum and/or NAc core were cut using a vibrating-
blade microtome (Leica VT1000 S). Tissue sections for analyses of dorsal striatum
were promptly processed for immunolabeling. Tissue sections for analyses of NAc
were stored in 1x PBS with NaN3 at 4 °C for processing at a later date. To start the
preparation of tissue for immunolabeling, sections were washed 3 × 5 min in 1×
PBS, placed into cryoprotectant (0.05 M PB, 25% sucrose, 10% glycerol) for a
minimum of 2 h and then freeze-thawed three times in liquid nitrogen to increase
penetration of the reagents. Sections were washed thoroughly and blocked with
10% normal goat serum in 1× PBS (Vector Laboratories: S-1000) for 1 h, followed
by overnight incubation in primary rabbit anti-TH antibody (1:1000, Chemicon:
#AB152) at RT. Sections were washed 3 × 5 min in 1× PBS and incubated in a gold-
conjugated goat anti-rabbit secondary antibody (1:400, 1.4 nm Nanogold,
Nanoprobes: #2003) for a minimum of 4 h at RT. TH-positive axons were revealed
with silver intensification of the conjugated gold particles. Silver reagent (1 ml;
Nanoprobes: HQ Silver Kit, prepared according to the manufacturer’s instructions)
was added to each section and allowed to react for 4.5 min in the dark, washed 3 ×
5 min in acetate buffer (0.1 M sodium acetate 3-hydrate, pH 7.0–7.5), and then 1×
PBS for 5 min. All sections were then washed 3 × 5min in 0.1 M PB. The sections
were post fixed in 1% osmium tetroxide in 0.1 M PB (OsO4; TAAB) for 12 min.
After washing 2 × 5min in 0.1 M PB, sections were dehydrated in an ascending
series of ethanol dilutions: 2 × 10 min in 50% ethanol; 45–60 min in 70% ethanol,
which included 1% uranyl acetate (TAAB); 10 min in 95% ethanol; and 2 × 10min
in absolute ethanol. Sections were washed 2 × 10min in propylene oxide (Sigma-
Aldrich), placed into resin (Durcupan ACM; Fluka), and left overnight (~15 h) at
RT. The resin was then warmed to reduce its viscosity, and sections were placed on
microscope slides, coverslipped, and the resin cured at 65 °C for ~70 h77,78.
Experimenters were blind to genotype throughout tissue processing and data
analysis.
Electron microscopy. All sections were examined under a light microscope to
select those containing striatal areas that were similar to those sampled in FCV
recordings. The selected areas of dorsolateral striatum and NAc core were cut from
the slide, glued to the top of a resin block, and trimmed with razor blades. For each
mouse, dorsal striatal regions from two sections across the rostro-caudal plane were
examined; for the NAc, the core region was examined from one section. Serial
sections, ~50 nm thick, were cut using an ultramicrotome (Leica EM UC6), col-
lected on pioloform-coated, single-slot copper grids (Agar Scientific), and lead
stained with Reynold’s lead citrate to improve contrast for electron microscopic
examination. For each region (block), ultrathin sections from at least two grids
were examined. A Philips CM100 or a Hitachi HT7800 transmission electron
microscope was used to examine the ultrathin sections of dorsal striatum or NAc,
respectively. Analyses of pre-embedded immunogold sections were performed at a
minimum of 5 µm from the tissue–resin border (i.e., section surface). The max-
imum distance from the tissue–resin border examined was determined by the
penetration of the gold-conjugated antibody together with the angle at which the
tissue–resin was sectioned, and was therefore variable. TH-positive structures were
systematically analyzed in one of the serial sections on an electron microscopic
grid. At a magnification at which it is not possible to clearly visualize synapses, an
area was chosen at random, the magnification was then increased and the first
structure positively labeled for TH was digitally recorded (with either a GatanCCD
UltraScan US1000 camera [Gatan] fitted to the Philips CM100, or with a XAROSA
CMOS camera [Emsis] fitted to the Hitachi HT7800). TH-positive structures were
identified and imaged, in this way, continuing systematically in straight lines across
the section, keeping the identified TH-positive structure central within the image
frame. For immunogold-labeled structures, the criterion for an immunopositive
structure was five or more silver-intensified immunogold particles. For dorsolateral
striatum, this was repeated for the second block until a minimum of 60 TH-
immunopositive structures were identified and imaged per animal (491 dopami-
nergic profiles in total, n= 4 mice per genotype). For the NAc core, 30 profiles
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were imaged per block (240 profiles in total, n = 4 mice per genotype). Symmetric
synapses (Gray’s type II) were identified by the presence of presynaptic and
postsynaptic membrane specializations, a widened synaptic cleft and cleft material.
Any TH-positive structures seen to be forming such symmetric synapses were
imaged68,79. Electron micrographs were acquired using the Digital Micrograph
(GATAN, release version 3) software for dorsal striatum and the Radius (EMSIS,
release version 2) software for NAc core.
EM analysis was performed blind to genotype. Digital images were analyzed
using Image J (NIH) and the Image J plug-ins PointDensity and PointDensitySyn
(https://liu.se/medfak/forskning/larsson-max/software?l=en; ref. 80). Images were
adjusted for contrast and brightness using Photoshop (version CS5; Adobe
Systems). For analysis of TH-positive structures, the central TH-positive structure
within the image frame was analyzed by tracing the perimeter. Other TH-positive
structures completely within the electron micrograph frame were also analyzed.
Analysis of immunogold-labeled TH-positive structures was performed using
PointDensity; after the perimeter of the central structure within the frame was
delineated, a point marker was placed within the center of each vesicle. Vesicles
were marked if at least 50% of the vesicle membrane was visible. If a structure was
observed to form a synaptic specialization, it was reanalyzed separately, and the
length of the active zone(s) was delineated and measured. The active zone was
defined as the length of plasma membrane directly opposing the postsynaptic
density, across the synaptic cleft. TH-positive profiles that were forming synapses
were analyzed separately using PointDensitySyn; the plasma membrane of the
structure was traced, the active zone(s) were delineated, and points were placed in
the center of the vesicles68,79. Cumulative distributions for EM data were analyzed
using Kolmogorov–Smirnov tests. Inter-vesicle distance data binned at 50 nm
intervals for dorsal striatum or 70 nm for NAc was analyzed using a two-way
ANOVA with Sidak’s multiple comparisons tests.
To confirm that the increased sampling of dorsal striatum profiles compared to
NAc profiles did not affect the statistical conclusions, we down-sampled the dorsal
striatum data to match the NAc data by randomly taking 30 profiles per mouse, for
a total of 120 profiles per genotype. The down-sampled data was highly
overlapping with the original full data set and genotype comparisons of profile
perimeter, area, number of vesicles, and vesicle density remained significantly
changed with a p value of <0.0001 (Kolmogorov–Smirnov test).
Behavior testing. Behavior testing was carried out in the dark phase of the light
cycle under red lights, except the rotarod and four-choice reversal tests, which were
carried out in the dark phase under white lights. Mice were habituated to the
behavior room for at least 30 min prior to testing and covered by a black-out
curtain. Mice were given at least one day in between different tests. All behavior
equipment was cleaned between each trial/mouse with 70% ethanol, and addi-
tionally rinsed in diluted soap followed by water at the end of the day. If male and
female mice were to be tested on the same day, male mice were tested first, returned
to the husbandry room, after which all equipment was thoroughly cleaned, and
female mice were brought in for habituation. Behavioral tests were performed with
P60–80 male and female mice, except for the four-choice test for which P70–130
male animals were used.
The experimenter was blind to genotype throughout the testing and scoring
procedures. Datasets with non-normal distributions were analyzed using a
Mann–Whitney test, datasets with a normal distribution were analyzed using two-
tailed unpaired t tests. Rotarod and four-choice reversal test were analyzed using a
two-way ANOVA with Sidak’s multiple comparisons tests. The three-chamber
social approach test was analyzed within genotype to test for significant differences
between mouse and object preference with paired t tests.
Four-choice odor-based reversal task. The four-choice odor-based reversal
task53 was used to assess learning and cognitive flexibility in adult male mice.
Animals were food restricted for 5–6 days in total with unrestricted access to
drinking water, and maintained at 85–90% of ad lib feeding body weight. Food was
given at the end of the day once testing was completed. Food restriction began 24 h
before pre-training.
The four-choice test was performed in a custom-made square box (30.5 cm L ×
30.5 cm W× 23 cm H) constructed of clear acrylic. Four internal walls 7.6 cm wide
partially divided the arena into four quadrants. A 15.2 cm diameter removable
cylinder fit in the center of the maze and was lowered between trials (after a digging
response) to isolate the mouse from the rest of the maze. Odor stimuli were
presented in white ceramic pots measuring 7.3 cm diameter and 4.5 cm deep. Pots
were sham baited with a cereal reward, either a Honey Nut Cheerio (General Mills,
Minneapolis, MN) or Fruit Loop cereal (Kellogg’s, Battle Creek, MI) secured
underneath a mesh screen at the bottom. The apparatus was cleaned with 2.5%
acetic acid followed by water between mice. Pots were cleaned with 70% ethanol
followed by water. The apparatus was cleaned with diluted soap and water at the
end of each testing day.
On the first habituation day of pre-training (day 1), animals were allowed to
freely explore the testing arena for 30 min and consume small pieces of Cheerios
placed inside empty pots positioned in each of the four corners. On the second
shaping day of pre-training (day 2), mice learned to dig to find cereal pieces buried
in unscented coarse pine wood shavings (Harts Mountain Corporation, Secaucus,
NJ). On the shaping day, animals that failed to consume Cheerio pieces were
switched to Fruit Loops, which they consumed successfully. A single pot was used
and increasing amounts of unscented wood shavings were used to cover each
subsequent cereal reward. The quadrant containing the pot was alternated on each
trial and all quadrants were rewarded equally. Trials were untimed and consisted of
(in order): two trials with no shavings, two trials with a dusting of shavings, two
trials with the pot a quarter full, two trials with the pot half full, and four trials with
the cereal piece completely buried by shavings. The mouse was manually returned
to the center cylinder between trials.
On the days for odor discrimination (day 3, aquisition) and reversal (day 4),
wood shavings were freshly scented on the day of testing (Table 1). Anise extract
(McCormick, Hunt Valley, MD) was used undiluted at 0.02 ml/g of shavings.
Clove, litsea, and eucalyptus oils (San Francisco Massage Supply Co., San
Francisco, CA) were diluted 1:10 in mineral oil and mixed at 0.02 ml/g of shavings.
Thymol (thyme; Alfa Aesar) was diluted 1:20 in 50% ethanol and mixed at 0.01 ml/
g of shavings. During the discrimination phase (day 3), mice had to discriminate
between four pots with four different odors and learn which one contained a buried
food reward (footnote a indicates the rewarded odor in the table below). Each trial
began with the mouse confined to the start cylinder, once the cylinder was lifted,
timing began and the mouse could freely explore the arena until it chose to dig in a
pot. Digging was defined as purposefully moving the shavings with both front
paws. A trial was terminated if no choice was made within 3 min and recorded as
omission. Criterion was met when the animal completed eight out of ten
consecutive trials correctly.
The reversal phase of the task was completed the following day after overnight
consolidation (day 4). Mice first performed the task with the same rewarded odor
as the discrimination day to ensure they learned and remembered the task. After
reaching criterion on recall (eight out of ten consecutive trials correct), the
rewarded odor was switched and mice undergo a reversal learning phase in which a
previously unrewarded odor is rewarded. Perseverative errors were choices to dig in
the previously rewarded odor that was no longer rewarded. Regressive errors were
choosing the previously rewarded odor after the first correct choice of the newly
rewarded odor. Novel errors were choices to dig in the pot with the newly
introduced odor for reversal testing. Irrelevant errors were choices to dig in the pot
that had never been rewarded. Omissions were trials in which the mouse failed to
make a digging choice within 3 min from the start of the trial. Total errors are the
sum of perseverative, regressive, irrelevant, novel, and omission errors. Criterion
was met when the mouse completed eight out of ten consecutive trials correctly.
The spatial location of the odors was shuffled on each trial.
Open-field test. Exploratory behavior in a novel environment and general loco-
motor activity were assessed by a 60-min session in an open-field chamber (40 cm
L × 40 cm W× 34 cm H) made of transparent plexiglas. Horizontal photobeams to
measure rearing were positioned at 9 cm height from the floor. The mouse was
placed in the bottom right hand corner of the arena and behavior was recorded
using an overhead camera and analyzed using the ANY-maze (Stoelting Co.)
behavior tracking software. An observer manually scored scratching and grooming
behavior during the first 20 min of the test.
Home cage observation. Home cage locomotor behavior and stereotypies in a
familiar environment were assessed by a 60 min session in the home cage (35 cm
L × 15 cm W× 12 cm H) made of transparent plexiglas. For group-housed animals,
observations were made for one mouse at a time, with cage mates removed to a
temporary cage and 30 min of additional habituation to the home cage once alone.
Locomotor behavior was recorded using an overhead camera and analyzed using
the ANY-maze (Stoelting Co.) behavior tracking software. Stereotypy behaviors
were recorded using an HD video camera positioned level with the cage and at 45°
angle to the cage floor, and scored manually during 1-min intervals every 6 min for
the total of 10 min of observation. An observer blind to genotype scored video
recordings for the number of instances a behavior of interest occurred. We
examined grooming (full grooming sequence, from face to hind side), facial only
grooming (whisker, ear and face grooming), taffy pulling (repetitive hand to mouth
movements), twirling (tight turns, complete circle), circling (follows vaguely cir-
cular path, loose turns), route tracing (walks back and forth along the same path),
repetitive jumping, repetitive sniffing, rearing (standing up on hind paws, without
side of the cage support), gnawing (chewing on things without the purpose of
eating them), yawning, swaying (whole body movements from side to side), and
sleeping.
Table 1 Odors used during acquisition and reversal learning
in the four-choice test.
Odor 1 Odor 2 Odor 3 Odor 4
Acquisition aAnise Clove Litsea Thyme
Reversal Anise aClove Litsea Eucalyptus
aThe odor rewarded on each testing day
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Elevated plus maze test. Exploratory behavior in a novel environment and
avoidance behavior were assessed with the elevated plus maze test81. The maze
consisted of four arms 30 cm long and 5 cm wide, with two open arms and two
arms enclosed by 16 cm tall walls painted black. The apparatus was custom made
out of Plexiglas plastic painted black and attached to sturdy Plexiglas plastic legs,
which elevated it 39 cm off the floor. At the start of the test, the mouse was placed
in the center square of the apparatus facing an open arm and allowed to freely
explore for 5 min. Behavior was recorded using a video camera positioned directly
above the center of the plus maze and analyzed using the ANY-maze (Stoelting
Co.) behavior tracking software. An entry into a closed or open arm was counted
when the mouse had all four paws in the arm.
Accelerating rotarod test. The accelerating rotarod test was used to examine
motor coordination, balance, and motor learning. Mice were run on a rotarod
apparatus (Ugo Basile: 47650) for 4 consecutive days. Three trials were completed
per day with a 5 min break between trials. The rotarod was accelerated from 5 to 40
revolutions per minute (r.p.m.) over 300 s for trials 1–6 (days 1 and 2), and from 10
to 80 r.p.m. over 300 s for trials 7–12 (days 3 and 4). On the first testing day, mice
were acclimated to the apparatus by being placed on the rotarod rotating at a
constant 5 r.p.m. for 60 s and returned to their home cage for 5 min prior to
starting trial 1. Latency to fall, or to rotate off the top of the rotarod barrel, was
measured by the rotarod stop–trigger timer. Motor coordination was defined as the
y intercept of the line of best fit from the first to last trial, and motor learning was
measured as the slope of performance from the first to last trial for each mouse.
Three-chamber social approach test. Social approach behavior was assessed
using the three-chamber social approach test82. The testing apparatus was made of
clear Plexiglas (60 cm L × 40 cm W× 22 cm H, Stoelting Co.). Two dividing walls
had doorways allowing access to three chambers. Age- and sex-matched C57BL/6J
mice were used as novel mice and were habituated to placement inside the wire
cups (8 cm diameter, 11 cm tall) prior to testing in either three 10-min or two 15-
min sessions. C57BL/6J mice that displayed persistent agitation, including climbing
or biting behavior inside the wire cups, were not used for testing.
The test mouse was placed in the center chamber of the apparatus and allowed
to explore and habituate to all three empty chambers for 10 min. The mouse was
then placed in the center chamber again for 5 min with access doors closed. During
this time, a novel C57BL/6J mouse was placed under a wire cup in one of the side
chambers and an empty wire cup was placed on the opposite side (novel object).
The chamber doors separating the three chambers were then removed to open
access to both left and right chambers. The mouse was allowed to explore the three
chambers for 10 min, and allowed to interact with the novel object or with the
stranger mouse inside the wire cup. The location of the stranger mouse and the
novel object were alternated between mice. Behavior was recorded using a video
camera positioned directly above the center of the apparatus and analyzed using
the ANY-maze (Stoelting Co.) behavior tracking software. An observer blind to
genotype manually scored time spent sniffing the novel mouse and the novel object
during the test. Sniffing was defined as when the mouse’s nose was perpendicular to
the vertical plane and <1 cm away from the wire cup. If the mouse reared on the
wire cup, climbed on the wire cup, or bit the wire cup, it was not scored as sniffing.
Mice showing a strong side bias during the habituation phase of the test were
excluded. Controls were DATIRESCre-negative littermates of DA-Tsc1-KO mice.
Comparisons were made within genotype.
Rapamycin treatment. Rapamycin (LC Laboratories) was prepared in ethanol at a
concentration of 30 mg/ml and stored at −80 °C until used. The stock solution was
diluted fresh on the day of injection by first adding 50% volume of 10% PEG-400
with 8% ethanol and then 50% volume of 10% Tween-80. All detergent dilutions
were made in sterile saline. Vehicle (the same carrier solution minus rapamycin) or
rapamycin were administered intraperitoneally 3 days a week (Monday, Wednes-
day, and Friday). Rapamycin was dosed at 8 mg/kg and injected starting at 4 weeks
of age. Rapamycin was administered for 8–11 weeks prior to perfusion and fixation,
including on the day of perfusion.
Quantification and statistical analysis. Whenever possible, quantification and
analyses were performed blind to genotype. All statistical analyses and graphing
were performed using the GraphPad Prism 6 or 8 software. All datasets were first
analyzed using D’Agostino and Pearson normality test, and then parametric or
non-parametric two-tailed statistical tests were employed accordingly to determine
significance. If the variances between two groups was significantly different, a
Welch’s correction was applied. Significance was set as *p < 0.05, **p < 0.01, ***p <
0.001, and ****p < 0.0001. P values were corrected for multiple comparisons. The
statistical tests used for each type of experiment are indicated above. Statistical
details for each experiment are reported in the figure legends.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Source data underlying all figures and tables are provided as a Source Data file.
Code availability
Code for the analysis of electron microscopy parameters was generated by Dr. Max
Larsson, Linkoping University, and is available at: https://liu.se/medfak/forskning/
larsson-max/software?l=en. ScanImage software was generated by Dr. Bernardo Sabatini,
Harvard Medical School, and is available at: https://github.com/bernardosabatini/
SabalabAcq.
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